G1 Therapeutics GTHX
$ 7.15
0.0%
Quarterly report 2024-Q2
added 08-08-2024
G1 Therapeutics Cash Flow 2011-2024 | GTHX
Annual Cash Flow G1 Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-38.3 M | -129 M | -132 M | -83.7 M | -99.6 M | -74.3 M | -50.5 M | -25.1 M | - | - | - | - | - |
Depreciation & Amortization |
513 K | 530 K | 469 K | 582 K | 356 K | 175 K | 89 K | 67 K | 42 K | - | - | - | - |
Accounts Payables |
3.99 M | 7.43 M | 2.9 M | 3.57 M | 3.68 M | 3.38 M | 4.18 M | - | - | - | - | - | - |
Accounts Receivables |
12.7 M | 11.1 M | 5.69 M | 237 K | - | - | - | - | - | - | - | - | - |
Total Inventories |
12.4 M | 16.2 M | 3.47 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow G1 Therapeutics
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -8.9 M | - | - | - | -29.1 M | - | -98 M | - | -38.2 M | - | -97.4 M | - | -26.9 M | - | -52.2 M | -55.9 M | -27 M | - | -69.6 M | -44.4 M | -21.5 M | - | -53.1 M | -36.3 M | -18.1 M | - | -35.8 M | -22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
121 K | 120 K | - | 127 K | 130 K | 132 K | - | 139 K | 139 K | 115 K | - | 355 K | 118 K | 120 K | 159 K | 462 K | 317 K | 159 K | - | 215 K | 129 K | 64 K | - | 115 K | 67 K | 32 K | - | 59 K | 32 K | 12 K | - | 44 K | 26 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
5.16 M | 5.11 M | 3.99 M | 7.34 M | 5.76 M | 5.38 M | 7.43 M | 8.44 M | - | 11 M | 2.9 M | 3.58 M | 3.64 M | 4.78 M | 3.57 M | 3.57 M | 3.57 M | 3.57 M | 3.68 M | 3.68 M | 3.68 M | 3.68 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 4.18 M | 4.18 M | 4.18 M | 4.18 M | 2.6 M | 2.6 M | 2.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
13.3 M | 11.7 M | 12.7 M | 9.26 M | 13.2 M | 16 M | 11.1 M | 10.5 M | - | 7.62 M | 5.69 M | 5.24 M | 4.96 M | 5.05 M | 237 K | 237 K | 237 K | 237 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
13.4 M | 12.5 M | 12.4 M | 13.5 M | 15.6 M | 15.5 M | 16.2 M | 14 M | - | 7.86 M | 3.47 M | 1.38 M | 1.4 M | 1.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency